NCT02069340 2017-04-11Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic AcidUniversity of Southern CaliforniaPhase NA Withdrawn
NCT00241111 2017-03-06Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone MetastasisNovartisPhase 4 Completed148 enrolled